Provider
Interleukin-13 (IL-13) Antagonist - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Search Results
Displaying 4141 - 4150 of 4182 results
Provider
Kerendia - Commercial
Step Therapy, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Otezla (apremilast) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Oxybate - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Ohtuvayre - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Interleukin-31 (IL-31) Inhibitor - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Journavx - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Presbyopia Agents - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Pain Medications - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Pseudobulbar Affect (PBA) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026